Woman Files Wegovy Gastroparesis Lawsuit After Requiring Stomach Emptying Procedure

Novo Nordisk Faces Legal Action Over Wegovy Side Effects

Novo Nordisk, the manufacturer of the weight loss drug Wegovy, is facing a product liability lawsuit filed by Jenny Bryant, a woman from New York. Bryant alleges that the company failed to adequately warn users and doctors about the actual risk of gastroparesis associated with Wegovy, which led to her requiring surgery to empty the contents of her stomach due to the side effects of the medication.

5 Key Points

  • Wegovy (semaglutide) is a higher-dose version of the diabetes drug Ozempic, belonging to the class of GLP-1 receptor agonists.
  • The lawsuit claims Novo Nordisk failed to warn that the risk of Wegovy gastroparesis side effects was dose-specific.
  • Bryant experienced severe gastrointestinal symptoms after taking Wegovy injections and required a stomach emptying procedure.
  • The lawsuit seeks compensatory and punitive damages for Bryant’s injuries.
  • Many Ozempic and Wegovy lawsuits have been centralized in multidistrict litigation (MDL) in the Eastern District of Pennsylvania.

Wegovy and Gastroparesis Risk

According to the complaint, Bryant began receiving once-weekly Wegovy injections in April 2023 to promote weight loss. The dosing schedule called for an increase in the injections from .25 mg to 2.4 mg. The lawsuit notes that “the higher the dose of the GLP-1 agonist, the more extreme the effects.” It alleges that Novo Nordisk did not adequately warn about the severe side effects associated with Wegovy, including acute and chronic gastrointestinal issues, deep vein thrombosis, sarcopenia, malnutrition, compromised body composition, hospitalization, and death.

Gastroparesis is a condition that affects the normal spontaneous movement of the stomach muscles, preventing proper stomach emptying. Symptoms can include nausea, vomiting, abdominal pain, bloating, and feeling full quickly when eating. In severe cases, such as Bryant’s, surgical intervention may be necessary to empty the stomach contents and alleviate symptoms.

Bryant’s Experience with Wegovy Side Effects

After each Wegovy injection, Bryant experienced vomiting, bloating, and upper abdominal pain. Despite being prescribed antinausea medications, her symptoms persisted even after discontinuing the injections in August 2023. An endoscopy in December revealed a food bolus, and a stomach emptying test in January confirmed severe gastroparesis.

Bryant’s case highlights the potential risks of Wegovy and the importance of adequate warnings for patients and healthcare providers. The lawsuit alleges that Novo Nordisk’s failure to properly inform users about the dose-specific risk of gastroparesis led to Bryant’s injuries and the need for invasive medical procedures.

Ozempic and Wegovy Lawsuit Update

With a growing number of similar claims filed in federal courts, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has centralized all gastroparesis lawsuits involving users of Wegovy, Ozempic, and other GLP-1 medications. Since February 2024, the litigation has been consolidated for pretrial proceedings before U.S. District Judge Gene E.K. Pratter in the Eastern District of Pennsylvania. The court will oversee discovery into common issues and is expected to schedule early “bellwether” test cases for trial. Thousands of claims are expected to be transferred to the Ozempic and Wegovy litigation as lawyers continue to review and file cases.

The centralization of these lawsuits aims to streamline the legal process, conserve resources, and ensure consistent rulings on common issues. As the litigation progresses, developments and the potential impact on patients who have experienced adverse effects from these widely prescribed medications will need to be monitored.

The Importance of Informed Consent and Adequate Warnings

Bryant’s case underscores the importance of informed consent and adequate warnings for prescription medications. Patients have the right to be fully informed about the potential risks and side effects associated with the prescribed drugs, allowing them to make informed decisions about their healthcare.

Pharmaceutical companies have a legal and ethical obligation to test their products thoroughly, disclose known risks, and provide accurate information to healthcare providers and patients. When drug manufacturers fail to fulfill these responsibilities, they may be held liable for the injuries and damages caused by their products.

As the Ozempic and Wegovy litigation progresses, it will be crucial to determine whether Novo Nordisk adequately warned about the risk of gastroparesis and other serious side effects associated with these medications. The outcome of these lawsuits may have significant implications for the pharmaceutical industry and how drug risks are communicated to the public.

Sean ‘Diddy’ Combs Files Motion to Dismiss Sex Trafficking Claim in Sexual Assault Lawsuit

Combs’ Legal Team Fights Back Against Joi Dickerson-Neal’s Accusations

In a recent development in the ongoing legal battle between music mogul Sean “Diddy” Combs and his accuser Joi Dickerson-Neal, Combs’ legal team has filed a motion to dismiss certain claims in the sexual assault lawsuit. The move comes as Combs faces mounting pressure from multiple lawsuits and investigations alleging sexual misconduct spanning several decades.

5 Key Points:

  • Sean “Diddy” Combs’ legal team filed a motion to dismiss some claims from a sexual assault lawsuit filed by Joi Dickerson-Neal.
  • The lawsuit accuses Combs of drugging and raping Dickerson-Neal in 1991 when she was a college student.
  • Combs’ lawyer argues that some claims were brought under laws that didn’t exist at the time of the alleged incident and against companies that were not yet formed.
  • Combs has denied all allegations, calling the incident a “money grab.”
  • Multiple agencies are investigating Combs for alleged sex trafficking and sexual assault, with raids conducted at his Los Angeles and Miami residences.


Motion to Dismiss Claims

Music mogul Sean “Diddy” Combs is fighting back against a sexual assault lawsuit filed by Joi Dickerson-Neal in November 2022. On Friday, Combs’ legal team filed a motion to dismiss some of the claims, arguing that they were brought under laws that didn’t exist and against companies that were not formed at the time of the alleged incident in 1991, according to documents obtained by USA TODAY [1].

Dickerson-Neal’s complaint, filed in Manhattan Supreme Court a day before the expiration of the New York State Adult Survivors Act, alleges that Combs drugged, sexually assaulted, and abused her when she was a college student at Syracuse University. The lawsuit also accuses Combs of distributing a videotape of the alleged assault to others in the music industry, causing “severe harm to Ms. Dickerson-Neal’s reputation, career prospects, and emotional well-being” [1].

However, Combs’ lawyer, Jonathan D. Davis, argues that the Adult Survivors Act does not permit Dickerson-Neal to “revive claims under statutes that did not exist,” including her claims of sex trafficking and revenge porn. The filing also states that Bad Boy Entertainment, Bad Boy Records, and Combs Enterprises, which are listed as defendants in the suit, did not exist when the alleged incident occurred and that “no allegations of wrongdoing are pled against them.” As a result, Davis concludes that Dickerson-Neal’s claims against these companies “fail as a matter of law” [1].

Combs Denies Allegations

Combs has denied all allegations against him, claiming that the incident was made up and a “money grab.” The lawsuit alleges that during a dinner date in January 1991, Combs intentionally drugged Dickerson-Neal by spiking her drink when she left it unattended to use the restroom, leaving her in a “physical state where she could not independently stand or walk” [1].

Multiple Lawsuits and Investigations

In addition to this lawsuit, Combs is facing multiple lawsuits filed in recent months claiming that he raped or sexually assaulted several alleged victims over the past few decades. He is also being investigated by multiple agencies, including Homeland Security Investigations, for alleged sex trafficking and sexual assault. Agents have raided Combs’ Los Angeles and Miami residences as part of these investigations [1].

As the legal battle continues, Dickerson-Neal has demanded a trial by jury. The outcome of this case and the ongoing investigations could have significant implications for Combs’ career and reputation in the music industry.